Dominik Bilicki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dominik Bilicki has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Gąsecka
1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland
1 shared publication - Grzegorz Procyk
1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland
1 shared publication - Marcin Grabowski
1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland
1 shared publication - Paweł Balsam
1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland
1 shared publication - Piotr Lodziński
1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
- 8 July 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (14) , 7591
Extracellular Vesicles in Atrial Fibrillation—State of the Art
Extracellular vesicles are particles released from cells and delimited by a lipid bilayer. They have been widely studied, including extensive investigation in cardiovascular diseases. Many scientists have explored their role in atrial fibrillation. Patients suffering from atrial fibrillation have been evidenced to present altered levels of these particles as well as changed amounts of their contents such as micro-ribonucleic acids (miRs). Although many observations have been made so far, a large randomized clinical trial is needed to assess the previous findings. This review aims to thoroughly summarize current research regarding extracellular vesicles in atrial fibrillation.
- 8 July 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (14) , 7591
Open AccessExtracellular Vesicles in Atrial Fibrillation—State of the Art
Extracellular vesicles are particles released from cells and delimited by a lipid bilayer. They have been widely studied, including extensive investigation in cardiovascular diseases. Many scientists have explored their role in atrial fibrillation. Patients suffering from atrial fibrillation have been evidenced to present altered levels of these particles as well as changed amounts of their contents such as micro-ribonucleic acids (miRs). Although many observations have been made so far, a large randomized clinical trial is needed to assess the previous findings. This review aims to thoroughly summarize current research regarding extracellular vesicles in atrial fibrillation.